Pancreatic Cancer Hero
Pancreatic Cancer

Mary Ann and Charles LaBahn Pancreatic Cancer Program

Register Now-12th Annual Pancreatic Cancer Symposium

Please join us for our 12th Annual Virtual Pancreatic Cancer Symposium on Friday, January 27, 2023. This symposium brings together experts in the field to provide the most up-to-date information on the diagnosis, staging, and state-of-the-art treatments.
Register Here
Erickson-George_stacked image component


Andrew Aguirre, MD, PhD - Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School

Andrew Biankin, AO, MBBS, PhD - Regius Chair of Surgery, Director of the Wolfson Wohl Cancer Research Center, University of Glasgow

Kathleen Christians, MD - Professor of Surgery with Tenure, Division of Surgical Oncology, Service Chief of Surgical Oncology GI Service, Medical College of WI

Douglas Evans, MD - Chair, Department of Surgery, Donald C. Ausman Family Foundation Chair, Medical College of WI

William A. Hall, MD - Associate Professor, Departments of Radiation Oncology and Surgery, Medical College of WI

Mandana Kamgar, MD, MPH - Assistant Professor, Division of Hematology and Oncology, Medicine, Department of Medicine, Medical College of WI

Alexandria T. Phan, MD -Professor, Department of Medicine, Medical College of WI

David T. Ting, MD - Associate Clinical Director for Innovation, Director, Tumor Cartography Center; Director, Biomarker Discovery Lab, Zebunisha Juma Endowed Chair, Harvard Medical School

A Gift that Continues Our Tradition of Leading the Way

Endowed through a generous gift from Mary Ann and Charles LaBahn, the Pancreatic Cancer Program is comprised of a multidisciplinary team of physicians, scientists, and dedicated staff who share the LaBahns' passion and urgency for making significant progress in the battle against pancreatic cancer.

The Mary Ann and Charles LaBahn Pancreatic Cancer Program serves as a hub for innovation where physicians and scientists are focused on providing hope for a cure to patients and families with pancreatic cancer. The LaBahns’ generosity allows for high-risk, high-reward research leading toward more effective therapies and treatment options for patients with this devastating disease. This philanthropic investment will hasten the pace at which our team can translate laboratory discoveries into treatments for patients.

Mary Ann and Charles LaBahn
Amanda in Surgery.

Our "Surgery Last" Approach 

Because of the complicated nature of pancreatic cancer, we believe that multidisciplinary care is the best option for successful treatment. This is especially important for patients with localized, operable cancer, since multimodality treatments have been shown to deliver the best outcomes. Our program helped to spearhead the “surgery last” approach, which advocates for quick and early delivery of chemotherapy and radiation. Not only does this promote an increased chance of controlling the cancer, it sets the stage for a positive surgical outcome.

Learn more about our program

Pancreatic Cancer Meet the Team

Meet the Team

Our team is here for you every step of the way.

learn more
Residents from surgical oncology.

Patient Education

We provide support through patient education.

learn more
Dr. Tsai in the lab.


Our research is advancing pancreatic cancer care.

Learn More
Physician and patient hands desk discussion

Clinical Trials

Our clinical trials provide ground-breaking treatment opportunities.

learn more


Contact and Appointment Information

Froedtert & the Medical College of Wisconsin Clinical Cancer Center
9200 W. Wisconsin Ave.
Milwaukee, WI 53226

New Patient Coordinator
(414) 805-6849
(414) 805-6848
(414) 805-8775 (fax)

Mailing Address
Medical College of Wisconsin
Division of Surgical Oncology
8701 Watertown Plank Rd.
Milwaukee, WI 53226


Administrative Offices
(414) 955-1400
(414) 955-0197 (fax)

Medical College of Wisconsin Google map location